CD79A Antibody (706931) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # FAB69201D
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 706931
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human CD79A
Leu33-Arg143
Accession # P11912
Leu33-Arg143
Accession # P11912
Specificity
Detects human CD79A in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant
mouse CD79A is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for CD79A Antibody (706931) [DyLight 350]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD79A
Alternate Names
CD79A, MB-1
Gene Symbol
CD79A
Additional CD79A Products
Product Documents for CD79A Antibody (706931) [DyLight 350]
Product Specific Notices for CD79A Antibody (706931) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...